OR WAIT null SECS
May 15, 2008
Also, Quintiles Transnational to acquire Eidetics, ChemAxon appoints Alex Drijver CEO, more...
Researchers at the University of Southern California's Information Sciences Institute (ISI) demonstrated a way to manufacture miniscule containers called voxels that could potentially deliver precise microdoses or even nanodoses of drugs.
May 08, 2008
Also, FDA removes OAI status for Watson's Florida facility, executive management changes as GSK, more...
Polyplus-transfection, a company that researches, develops, and commercializes drug-delivery solutions for biomolecules, created a new technology designed to enhance in vivo delivery of small interfering RNAs (siRNAs) when they are associated with a cationic polymer.
May 02, 2008
Scientists are giving up on a preventive vaccine for AIDS, but there are lessons to be learned.
May 01, 2008
Insulin is one of the world's oldest and most well-known biological drugs, and the need for it is not going to go away as the number of patients diagnosed with diabetes continues to increase. A wealth of clinical evidence shows that good, long-term glucose control in diabetes is key to avoiding complications such as kidney disease, blindness and heart problems.
The adequate absorption and transport of drugs in the body is part of optimal therapy. Drug administration perorally is easy, common and traditional, but occasionally alternative routes are required.
April 30, 2008
Also, Genzyme to build R&D center in Beijing, Noven Pharmaceuticals appoints Peter C. Brandt president and CEO, more...
April 22, 2008
Also, GSK expands in Ireland, executive appointments at ProGenTech, more...
April 16, 2008
MannKind suspended discussions with potential partners for the commercialization of its "Technosphere Insulin" product.